Several studies have shown KLF4 is critical mediator of obesity‐related complications, including cardiomyopathy, systemic inflammation and metabolic syndromes.13, 24 Therefore, present study further explored the effects of renal KLF4 in obesity‐related nephropathy. Here, KLF4 is linked to cardiomyopathy.